Non-interventional Observational Study With Viramune Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data

Trial Profile

Non-interventional Observational Study With Viramune Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jan 2015

At a glance

  • Drugs Nevirapine (Primary) ; Antiretrovirals
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors Boehringer Ingelheim Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 06 Mar 2013 Planned end date changed from 1 Mar 2015 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top